References
- PriceDFromerLKaplanAvan der MolenTRomán-RodríguezMIs there a rationale and role for long-acting anticholinergic bronchodilators in asthma?NPJ Prim Care Respir Med2014241402325030457
- KerstjensHADisseBSchröder-BaboWTiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trialJ Allergy Clin Immunol201112830831421636120
- KerstjensHAEngelMDahlRTiotropium in asthma poorly controlled with standard combination therapyN Engl J Med20123671198120722938706
- WilsonJBatemanEDPavordILloydAKrivasiTEsserDCost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonistsAppl Health Econ Health Policy20141244745924974107
- KapoorASOlsenSRO’HaraCPuttaguntaLVethanayagamDThe efficacy of tiotropium as a steroid-sparing agent in severe asthmaCan Respir J2009169910119557217
- AdamsKSLoweDKTiotropium for adults with inadequately controlled persistent asthmaAnn Pharmacother20134711712323324511
- HylandMEWhalleyBJonesRCMasoliMA qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scalesQual Life Res992014 Epub ahead of print
- Summary of Product CharacteristicsSpiriva Respimat 2.5 micrograms solution for inhalationElectronic Medicines Compendium Available from: http://www.medicines.org.uk/emc/medicine/20134Accessed October 13, 2014
- FardonTHaggartKLeeDKLipworthBJA proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthmaRespir Med20071011218122817178217
- BatemanEDKornmannOSchmidtPPivovarovaAEngelMFabbriLMTiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthmaJ Allergy Clin Immunol201112831532221807250
- BeehKMMoroni-ZentgrafPAblingerOTiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult asthma patients with moderate asthmaRespir Res2014156124890738
- VogelbergCEngelMMoroni-ZentgrafPTiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging studyRespir Med20141081268127625081651
- PetersSPKunselmanSJIcitovicNTiotropium bromide step-up therapy for adults with uncontrolled asthmaN Engl J Med20103631715172620979471
- RocheNReddelHKAgustiAIntegrating real-life studies in the global therapeutic research frameworkLancet Respir Med20131e29e3024461762
- Summary of Product CharacteristicsSpiriva 18 microgram inhalation powderElectronic Medicines Compendium Available from: http://www.medicines.org.uk/emc/medicine/10039Accessed October 13, 2014
- HohlfeldJMSharmaAvan NoordJAPharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary diseaseJ Clin Pharmacol20145440541424165906
- MathioudakisAGChatzimavridou-GrigoriadouVEvangelopoulouEMathioudakisGASiafakasNMComparative mortality risk of tiotro-pium administered via Handihaler or Respimat in COPD patients: are they equivalent?Pulm Pharmacol Ther201428919724846455
- ReddelHKTaylorDRBatemanEDAn official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbationsAm J Respir Crit Care Med2009180595919535666
- British Thoracic SocietySIGN 141. British guideline on the management of asthmaLondon, UK2014 Available from: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2014/Accessed October 13, 2014
- SimsEJPriceDHaughneyJRyanDThomasMCurrent control and future risk in asthma managementAllergy Asthma Immunol Res2011321722521966601